Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis. Izquierdo G, O'Connor P, Montalban X, von Rosenstiel P, Cremer M, de Vera A, Sfikas N, Francis G, Radue E, Kappos L Mult Scler. 2013 Nov 30. PMID: 24293455. Abstract CommentRecommendBookmarkWatch